Epidermal Growth Factor Receptor Inhibition for Keratinopathies

NCT06545695 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Epidermolytic Ichthyosis
Palmoplantar Keratoderma
Pachyonychia Congenita

Interventions

DRUG: Erlotinib

Sponsor

Northwestern University

Collaborators

[object Object]